Stay updated on Esketamine Safety in Treatment-Resistant Depression Clinical Trial
Sign up to get notified when there's something new on the Esketamine Safety in Treatment-Resistant Depression Clinical Trial page.

Latest updates to the Esketamine Safety in Treatment-Resistant Depression Clinical Trial page
- Check2 days agoChange DetectedThe site revision displayed in the footer changes from v3.7.2 to v3.8.0.SummaryDifference0.0%

- Check9 days agoChange DetectedA site-wide NIH notice says federal agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence” and links to related updates and FAQs.SummaryDifference0.3%

- Check16 days agoChange DetectedThe site revision displayed in the footer changed from v3.7.1 to v3.7.2.SummaryDifference0.0%

- Check23 days agoChange DetectedThe footer now displays site revision v3.7.1 instead of v3.7.0.SummaryDifference0.0%

- Check43 days agoChange DetectedRevision updated from v3.6.6 to v3.7.0 in the page footer, indicating a new version of the study record history. This is a metadata/version update that tracks changes to the record rather than altering the study content.SummaryDifference0.0%

- Check64 days agoChange DetectedRevision label updated from v3.6.5 to v3.6.6, indicating a new revision of the study record history was published. It represents an update to the page's version history rather than content changes.SummaryDifference0.0%

Stay in the know with updates to Esketamine Safety in Treatment-Resistant Depression Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Esketamine Safety in Treatment-Resistant Depression Clinical Trial page.